Michelle M. Mello's Testimony Before the U.S. Senate Committee on Finance
Michelle M. Mello discusses how Congress can support healthcare organizations and health insurers navigating the uncharted territory of AI tools by imposing some guardrails while allowing the rules to evolve with the technology.
Introduction
I have the extraordinary privilege of being part of a group of ethicists, data scientists, and physicians at Stanford University—long a leading hub of AI innovation—that is directly involved in governing how healthcare AI tools are used in patient care. I have studied patient safety, healthcare quality regulation, and data ethics for more than two decades. I apply that expertise in our team’s evaluations of all AI tools proposed for use in Stanford Health Care facilities, which care for over 1 million patients per year, and our recommendations about whether and how they can be used safely and effectively.